According to Design Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.34. In 2022 the company made an earnings per share (EPS) of -$1.14 a decrease over its 2021 EPS that were of -$0.86.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.34 | 17.54% |
2022 | -$1.14 | 32.56% |
2021 | -$0.86 | 266.96% |
2020 | -$0.23 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$2.18 | 62.69% | ๐บ๐ธ USA |